We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,183.00
Bid: 2,178.00
Ask: 2,180.00
Change: -17.00 (-0.77%)
Spread: 2.00 (0.092%)
Open: 2,191.00
High: 2,196.00
Low: 2,158.00
Prev. Close: 2,200.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

21 Jul 2016 07:00

RNS Number : 7939E
Halma PLC
21 July 2016
 

Halma plc

 

AGM Trading Update 21 July 2016

 

Halma, the leading safety, health and environmental technology group is holding its 122nd AGM later today. The following comments on trading relate to the first quarter of Halma's financial year which ended on 2 July 2016.

 

Halma has continued to make good progress in line with the Board's expectations. Revenue was ahead of the first quarter of the prior year and included good organic constant currency growth on a weekly average basis (see Note 2). Order intake was ahead of revenue and also above order intake in the first quarter of the prior year.

 

There was strong revenue growth in the Infrastructure Safety and Medical sectors with steady progress in the Environmental & Analysis sector. As expected there was lower revenue in Process Safety; based on improving order intake trends and continued diversification, the sector is better positioned to improve its performance as the year progresses.

 

There was revenue growth in all of our major geographic regions, with the highest rates of growth in the USA and Mainland Europe.

 

At the end of June, Sterling weakened relative to many currencies, including the US Dollar and Euro. If current exchange rates continue throughout the rest of the current financial year, the currency translation impact on the Group's results is expected to be positive. Based on the current mix of currency denominated revenue and profit, a 1% movement in the US Dollar changes full year revenue by £4.3m and profit by £0.9m. Similarly, a 1% movement in the Euro changes full year revenue by £1.1m and profit by £0.2m. The weighted average exchange rates relative to Sterling used to translate revenue and profit for the year ended 2 April 2016 were: US Dollar 1.51, Euro 1.37.

 

The Board remains confident that the resilient and global long-term growth drivers in our chosen markets will continue to underpin Halma's growth. Our focus on safety, health and environmental technologies together with our agile organisational model, which encourages local decision making within each subsidiary company, ensures that our business is able to adapt quickly to changing market conditions. We continue to identify potential acquisition opportunities that meet our strategic and financial criteria.

 

In July 2016, Paul Simmons was promoted to the Halma Executive Board as Sector Chief Executive of our Infrastructure Safety sector, following Nigel Trodd's decision to retire from the Group in mid-2017. Paul joined Halma as a subsidiary Managing Director in 2010 and was promoted to Sector Vice President of Infrastructure Safety in 2014. Since then, he has chaired most of the Sector businesses and played a significant role in the acquisition of both Advanced Electronics in 2014 and Firetrace in 2015. Nigel will continue to ensure a smooth management transition process and actively support the Sector's M&A activities.

 

The Group's financial position remains strong.

The half yearly results for the period ending 1 October 2016 are expected to be released on 22 November 2016.

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

 

NOTE TO EDITORS

1.

Halma develops and markets products used worldwide to protect life and improve the quality of life. The Group comprises four business sectors:

 

Pr Process Safety

Products which protect assets and people at work.

InfInfrastructure Safety

Products which detect hazards to protect assets and people in public spaces and commercial buildings.

 

M Medical

Products used to improve personal and public health.

 

En Environmental &

& Analysis

Products and technologies for analysis in safety, life sciences and environmental markets.

 

 

 

The key characteristics of Halma's businesses are that they are based on specialist technology and application knowledge, offering strong growth potential. Many Group businesses are market leaders in their specialist field.

 

2.

The first quarter's trading in the current 2016/17 financial year included 13 weeks from 3 April 2016 to 2 July 2016. The first quarter's trading in the 2015/16 financial year included 14 weeks from 29 March 2015 to 4 July 2015.

3.

High-resolution photos of Halma senior management, including Chief Executive Andrew Williams, and images illustrating Halma business activities can be downloaded from its website: www.halma.com. Click on the 'News & Media' link, then 'Image Library'. Photo queries: David Waller +44 (0)1494 721111, e-mail: dwaller@halmapr.com.

 

4.

This Trading Update has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

 

5.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

     

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGZNVGLGVZM
Date   Source Headline
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.